Chuangmo Bio
创模生物
Chuangmo Bio
Biotech/Healthcare
Chuangmo Biotechnology specializes in oncology and immuno-oncology pharmacology CRO services. The company develops next-generation in vitro and laboratory animal models for oncology and immuno-oncology drug efficacy studies.
Latest round: Angel (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-10-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.